Interaction of multiple sclerosis serum with liposomes containing ganglioside GM1
β Scribed by Dr. Brian R. Mullin; Anthony J. Montanaro; J. D. Reid; Robert N. Nishimura
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 321 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Multiple sclerosis serum contains a factor or factors capable of releasing sequestered [^14^C]glucose from liposomes containing G~M1~, the major ganglioside present in human central nervous system myelin. Although some control sera can also release large quantities of liposomal glucose, multiple sclerosis and control sera differ in the mechanism of this release. Liposomal damage by multiple sclerosis serum does not appear to be complement mediated, but shares certain releasing characteristics of cholera toxin.
π SIMILAR VOLUMES
The fluorescence lifetime, quantum yield and emission spectra of 1-anilinonaphthalene 8-sulfonic acid (ANS) associated with interfaces of pure dipalmitoylphosphafidylcholine or its mixtures with phosphatidylserine, galactosylceramide, sulfatide or gangliosides GM1 and Gin. were studied at low and hi
The growth-regulatory interplay between ganglioside GM1 on human SK-N-MC neuroblastoma cells and an endogenous lectin provides a telling example for glycan (polysaccharide) functionality. Galectin-1 is the essential link between the sugar signal and the intracellular response. The emerging intrafami
## Abstract We present the first evidence demonstrating that small fractions of IgGs of all four subclasses (IgG1βIgG4) are catalytically active in the hydrolysis of DNA and on average their relative activity (nM supercoiled DNA/1mg IgG/1βh) increases in the order: IgG1 (0.58)β<βIgG2 (0.94)β<βIgG3